For circulatory support in cardiogenic shock, the best choice between Impella and intra-aortic balloon pump (IABP) has been controversial. Now, new data is complicating the debate. Presenting at the ...
Major adverse cardiac and CV events were not reduced in patients with severe left ventricular dysfunction and extensive coronary disease who had an intra-aortic balloon inserted before percutaneous ...
An intra-aortic balloon pump is a temporary treatment to help the heart pump enough blood around the body, which people with certain heart conditions may require. An intra-aortic balloon pump (IABP) ...
Interv Cardiol. 2012;4(2):211-234. The future of IABC cannot, however, be taken in isolation. It must be analyzed in the context of other PCADs available for in-human use, namely the Impella Recover ...
The US Food and Drug Administration (FDA) has alerted users of Datascope Corp/MAQUET’s Cardiosave hybrid intra-aortic balloon pump (IABP) to a “design issue” that enables fluids to leak into the ...
CHICAGO, IL—Contrary to shorter-term results, follow-up beyond 4 years shows that elective intra-aortic balloon pump (IABP) therapy in high-risk patients receiving percutaneous coronary intervention ...
The balloon pump can help improve the heart’s ability to pump blood as it needs to. Through a surgical procedure, the device is inserted through your leg into the heart. This is a short-term solution ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback